Quick Answer
NovoCure Ltd reported Stockholders Equity of $340.47 million for the year ending 2025.
- NovoCure Ltd showed a decrease of -5.5% in Stockholders Equity from 2024 to 2025.
- This data is from NovoCure Ltd's annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2012 to 2025 (14 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q4 2014: $97.88 million | Q3 2015: $121.22 million | Q1 2016: $220.43 million | Q2 2016: $186.65 million | Q3 2016: $158.24 million | Q1 2017: $128.90 million | Q2 2017: $117.55 million | Q3 2017: $116.69 million | Q1 2018: $106.12 million | Q2 2018: $112.08 million | Q3 2018: $114.94 million | Q1 2019: $126.39 million | Q2 2019: $158.91 million | Q3 2019: $190.37 million | Q1 2020: $241.95 million | Q2 2020: $267.82 million | Q3 2020: $307.04 million | Q1 2021: $372.13 million | Q2 2021: $397.27 million | Q3 2021: $413.16 million | Q1 2022: $435.88 million | Q2 2022: $441.67 million | Q3 2022: $445.40 million | Q1 2023: $432.15 million | Q2 2023: $415.68 million | Q3 2023: $393.70 million | Q1 2024: $359.36 million | Q2 2024: $361.75 million | Q3 2024: $360.78 million | Q1 2025: $361.96 million | Q2 2025: $349.44 million | Q3 2025: $341.33 million.
- Over the full 14 years of available data (2012 to 2025), NovoCure Ltd's Stockholders Equity has grown by 588.9%.
- Historical annual values: Fiscal year 2025: $340.47 million | Fiscal year 2024: $360.18 million | Fiscal year 2023: $362.50 million | Fiscal year 2022: $441.17 million | Fiscal year 2021: $410.49 million | Fiscal year 2020: $476.53 million | Fiscal year 2019: $217.79 million | Fiscal year 2018: $112.26 million | Fiscal year 2017: $113.56 million | Fiscal year 2016: $142.35 million | Fiscal year 2015: $250.82 million | Fiscal year 2014: $97.88 million | Fiscal year 2013: $171.78 million | Fiscal year 2012: $49.43 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: